Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 14/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | PDE4A | P27815 | 2/20 | 0.54 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.54 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | PDE2A | O00408 | 1/20 | 0.54 |
| ▸ | RGS12 | O14924 | 1/20 | 0.54 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.54 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.54 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.54 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.54 |
| ▸ | PDE6D | O43924 | 1/20 | 0.54 |
| ▸ | PDE8A | O60658 | 1/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3395769 | 1.00 | SLC29A1 (0.54) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL15065643 | 0.93 | SLC29A1 (0.48) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL7446838 | 0.91 | SLC29A1 (0.47) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL9565592 | 0.90 | SLC29A1 (0.49) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL11564661 | 0.85 | SLC29A1 (0.42) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL9351966 | 0.85 | SLC29A1 (0.56) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL1956785 | 0.85 | SLC29A1 (0.41) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL2459706 | 0.84 | SLC29A1 (0.41) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL2458640 | 0.84 | SLC29A1 (0.41) | SLC29A1ALDH1A1LMNATSHRPDE4A | |
| SCHEMBL4077875 | 0.84 | SLC29A1 (0.43) | SLC29A1ALDH1A1LMNATSHRPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220087970-A1 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | THE JOHNS HOPKINS UNIVERSTY | 2022-03-24 | — | — | US | claimed |
| WO-2020150698-A1 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-07-23 | — | — | WO | claimed |
| US-5346772-A | HAVING A HIGH LUMINANCE AND HIGH EMISSION EFFICIENCY | PIONEER ELECTRONIC CORPORATION (JP) | 1994-09-13 | — | — | US | claimed |
| EP-0123841-B1 | MEDICAMENT WITH AN ATHEROPROTECTIVE HIGH DENSITY LIPOPROTEIN ENHANCING ACTIVITY, CONTAINING 2,6-BIS-DIETHANOLAMINO-4,8-DIPIPERIDINOPYRIMIDE (5,4-D) PYRIMIDINE | Dr. Karl Thomae GmbH (DE) | 1989-09-20 | — | — | EP | claimed |
| EP-0019586-A1 | Antithrombotic combination formulas | CIBA-GEIGY AG (CH) | 1980-11-26 | — | — | EP | claimed |
| EP-0000774-A1 | Antithrombotic medicative combination and process for its preparation | Dr. Karl Thomae GmbH (DE) | 1979-02-21 | — | — | EP | claimed |
| JP-7258084-A | — | — | None | — | — | JP | disclosed |
| JP-55147295-A | — | — | None | — | — | JP | disclosed |
| JP-57209291-A | — | — | None | — | — | JP | disclosed |
| US-20230149427-A1 | COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE | THEAPRIN PHARMACEUTICALS, INC. | 2023-05-18 | — | — | US | disclosed |
| US-20220087970-A1 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | THE JOHNS HOPKINS UNIVERSTY | 2022-03-24 | — | — | US | disclosed |
| WO-2020150698-A1 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-07-23 | — | — | WO | disclosed |
| US-10357453-B2 | Methods of eye treatment using therapeutic compositions containing dipyridamole | O.D. OCULAR DISCOVERY LTD. (IL) | 2019-07-23 | — | — | US | disclosed |
| EP-0019586-A1 | Antithrombotic combination formulas | CIBA-GEIGY AG (CH) | 1980-11-26 | — | — | EP | disclosed |
| JP-S55147295-A | PREPARATION OF DIPHOSPHOGLYCERIC ACID SALT | NIPPON SHINYAKU CO LTD | 1980-11-17 | — | — | JP | disclosed |
| US-4206214-A | Antithrombotic pharmaceutical compositions containing dipyridamole and sulfinpyrazone | BOEHRINGER INGELHEIM GMBH (DE) | 1980-06-03 | — | — | US | disclosed |
| EP-0000774-B1 | ANTITHROMBOTIC MEDICATIVE COMBINATION AND PROCESS FOR ITS PREPARATION | Dr. Karl Thomae GmbH (DE) | 1980-05-28 | — | — | EP | disclosed |
| US-4174395-A | 4-[4-(2-Methyl-3-hydroxy-4-hydroxymethyl-5-pyridyl-methyl)-1-piperazinyl]-6-methylpyrimidines | SOCIETE CIVILE DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) | 1979-11-13 | — | — | US | disclosed |
| EP-0000774-A1 | Antithrombotic medicative combination and process for its preparation | Dr. Karl Thomae GmbH (DE) | 1979-02-21 | — | — | EP | disclosed |
| US-3961071-A | CARDIOVASCULAR DISORDERS, 1-PHENOXY-2-HYDROXY-3-TERT-BUTYLAMINO PROPANES | BOEHRINGER INGELHEIM GMBH (DT) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230149427-A1 | COMPOSITIONS COMPRISING COCRYSTALS OF ACETYLSALICYLIC ACID AND THEANINE WITH TROMETHAMINE AND METHODS OF USE | PTGIS, PTGES, PTGS1 | SLC29A1 258/4885ALDH1A1 418/4885LMNA 4565/4885 |
| US-20220087970-A1 | PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION | PYGB, PRKG1, ACHE | SLC29A1 2272/4885ALDH1A1 1525/4885LMNA 2070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.